Sherwin-Williams (NYSE:SHW – Get Free Report) had its price target lifted by stock analysts at Citigroup from $355.00 to $380.00 in a research report issued on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the specialty chemicals company’s stock. Citigroup’s target price would suggest a potential upside of 14.08% from the stock’s current price.
Several other analysts have also issued reports on SHW. Berenberg Bank set a $380.00 target price on Sherwin-Williams in a research note on Monday, June 8th. Evercore reissued an “outperform” rating on shares of Sherwin-Williams in a research report on Friday, May 8th. Bank of America reduced their price objective on shares of Sherwin-Williams from $370.00 to $365.00 and set a “neutral” rating for the company in a research note on Tuesday, April 21st. Royal Bank Of Canada dropped their price objective on Sherwin-Williams from $390.00 to $376.00 and set an “outperform” rating on the stock in a report on Thursday, March 19th. Finally, Wells Fargo & Company reduced their target price on Sherwin-Williams from $365.00 to $350.00 and set an “equal weight” rating for the company in a report on Wednesday, April 29th. Eight research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $368.69.
Get Our Latest Research Report on SHW
Sherwin-Williams Stock Up 3.2%
Sherwin-Williams (NYSE:SHW – Get Free Report) last announced its quarterly earnings results on Tuesday, April 28th. The specialty chemicals company reported $2.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.27 by $0.08. Sherwin-Williams had a return on equity of 64.55% and a net margin of 10.86%.The business had revenue of $5.67 billion during the quarter, compared to the consensus estimate of $5.56 billion. During the same quarter in the prior year, the company posted $2.25 earnings per share. Sherwin-Williams’s revenue was up 6.9% compared to the same quarter last year. Sherwin-Williams has set its FY 2026 guidance at 11.500-11.900 EPS. Equities analysts predict that Sherwin-Williams will post 11.77 EPS for the current year.
Institutional Investors Weigh In On Sherwin-Williams
A number of large investors have recently added to or reduced their stakes in SHW. Wilkerson Advisory Group LLC increased its holdings in Sherwin-Williams by 172.4% during the 1st quarter. Wilkerson Advisory Group LLC now owns 79 shares of the specialty chemicals company’s stock valued at $25,000 after purchasing an additional 50 shares during the period. Ares Financial Consulting LLC bought a new stake in shares of Sherwin-Williams in the 4th quarter worth approximately $27,000. Lloyd Advisory Services LLC. purchased a new position in shares of Sherwin-Williams during the fourth quarter valued at approximately $27,000. Whipplewood Advisors LLC purchased a new position in shares of Sherwin-Williams during the first quarter valued at approximately $28,000. Finally, Kemnay Advisory Services Inc. bought a new position in shares of Sherwin-Williams during the fourth quarter valued at approximately $30,000. Hedge funds and other institutional investors own 77.67% of the company’s stock.
About Sherwin-Williams
Sherwin-Williams (NYSE: SHW) is a global manufacturer and distributor of paints, coatings and related products. Founded in 1866 and headquartered in Cleveland, Ohio, the company supplies a broad range of coatings for residential, commercial and industrial applications. Its product offering includes architectural paints and stains, industrial and protective coatings, automotive finishes, and a variety of sundry products such as primers, sealants and specialty treatments used by professionals and consumers.
The company sells through multiple channels, including a large network of company-operated retail paint stores that serve professional contractors and do-it-yourself consumers, as well as through distributors and mass retailers.
Further Reading
- Five stocks we like better than Sherwin-Williams
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Receive News & Ratings for Sherwin-Williams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sherwin-Williams and related companies with MarketBeat.com's FREE daily email newsletter.
